2026-2030年全球藥物傳輸設備市場

全球藥物輸送設備市場預計在 2025 年至 2030 年間成長至 991.879 億美元，預測期內複合年成長率為 6.4%。

這份關於全球藥物輸送設備市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場發展的因素包括慢性病盛行率上升、全球人口老化、生物製藥和大分子療法的普及，以及數位促進的居家醫療和自我管理模式的轉變。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、包含區域分析的細分市場資訊以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，將數位健康和​​互聯技術融入藥物輸送設備是未來幾年全球藥物輸送設備市場成長的關鍵促進因素之一。此外，對以患者為中心的護理和人體工學的日益重視，以及用於大容量、高黏度生物製藥的先進設備的研發，預計也將產生顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球藥物傳輸設備市場
• 按給藥途徑分類的細分市場分析，2020-2024 年
• 基於應用領域的細分市場分析，2020-2024 年
• 2020年至2024年最終用戶細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球藥物傳輸設備市場
• 地緣政治衝突的影響：全球藥物輸送設備市場

第7章：五力分析

第8章 市場區隔：依給藥途徑

• 比較：按給藥途徑
• 口服
• 注射藥物
• 肺
• 其他
• 市場機會：依給藥途徑分類

第9章 市場區隔：依應用

• 比較：按應用
• 腫瘤學
• 糖尿病
• 呼吸系統疾病
• 心血管疾病
• 其他
• 市場機會：依應用領域分類

第10章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院
• 家庭醫療保健
• 門診手術中心
• 其他
• 市場機會：依最終用戶分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • 土耳其
  • UAE
  • 阿根廷
  • 南非
  • 哥倫比亞
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• AptarGroup Inc.
• B.Braun SE
• Baxter International Inc.
• Becton Dickinson and Co.
• Gerresheimer AG
• Halozyme Therapeutics Inc.
• ICU Medical Inc.
• Insulet Corp.
• Medtronic Plc
• Nipro Corp.
• Stevanato Group SpA
• Tandem Diabetes Care Inc.
• Terumo Corp.
• West Pharma Services Inc.
• Ypsomed Holding AG

第16章附錄

The global drug delivery devices market is forecasted to grow by USD 99187.9 mn during 2025-2030, accelerating at a CAGR of 6.4% during the forecast period. The report on the global drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases and aging global population, proliferation of biologic and large molecule therapies, shift toward home healthcare and self-administration enhanced by digitalization.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global drug delivery devices market is segmented as below:

By Route Of Administration

• Oral
• Injectable
• Pulmonary
• Others

By Application

• Oncology
• Diabetes
• Respiratory diseases
• Cardiovascular diseases
• Others

By End-User

• Hospitals
• Home healthcare
• Ambulatory surgery centers
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of digital health and connectivity in delivery devices as one of the prime reasons driving the global drug delivery devices market growth during the next few years. Also, deepening focus on patient centricity and human factors engineering and development of advanced devices for large volume and high viscosity biologics will lead to sizable demand in the market.

The report on the global drug delivery devices market covers the following areas:

• Global drug delivery devices market sizing
• Global drug delivery devices market forecast
• Global drug delivery devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global drug delivery devices market vendors that include AptarGroup Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Enable Injections, Gerresheimer AG, Halozyme Therapeutics Inc., ICU Medical Inc., Insulet Corp., Kindeva Drug Delivery L.P., Medtronic Plc, Nemera Group, Nipro Corp., Owen Mumford Ltd., SHL Medical AG, Stevanato Group S.p.A, Tandem Diabetes Care Inc., Terumo Corp., West Pharma Services Inc., Ypsomed Holding AG. Also, the global drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Drug Delivery Devices Market 2020 - 2024
  • Historic Market Size - Data Table on Global Drug Delivery Devices Market 2020 - 2024 ($ million)
• 5.2 Route of Administration segment analysis 2020 - 2024
  • Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Drug Delivery Devices Market
• 6.2 Impact of Geopolitical Conflicts on Global Drug Delivery Devices Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Route of Administration

• 8.1 Market segments
• 8.2 Comparison by Route of Administration
• 8.3 Oral - Market size and forecast 2025-2030
• 8.4 Injectable - Market size and forecast 2025-2030
• 8.5 Pulmonary - Market size and forecast 2025-2030
• 8.6 Others - Market size and forecast 2025-2030
• 8.7 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Oncology - Market size and forecast 2025-2030
• 9.4 Diabetes - Market size and forecast 2025-2030
• 9.5 Respiratory diseases - Market size and forecast 2025-2030
• 9.6 Cardiovascular diseases - Market size and forecast 2025-2030
• 9.7 Others - Market size and forecast 2025-2030
• 9.8 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Hospitals - Market size and forecast 2025-2030
• 10.4 Home healthcare - Market size and forecast 2025-2030
• 10.5 Ambulatory surgery centers - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 Turkey - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 South Africa - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of chronic diseases and aging global population
  • Proliferation of biologic and large molecule therapies
  • Shift toward home healthcare and self-administration enhanced by digitalization
• 13.2 Market challenges
  • Navigating complex and evolving regulatory landscape
  • Balancing innovation with cost containment and reimbursement pressures
  • Managing product recalls, device reliability, and cybersecurity risks
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of digital health and connectivity in delivery devices
  • Deepening focus on patient centricity and human factors engineering
  • Development of advanced devices for large volume and high viscosity biologics

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AptarGroup Inc.
  • AptarGroup Inc. - Overview
  • AptarGroup Inc. - Business segments
  • AptarGroup Inc. - Key news
  • AptarGroup Inc. - Key offerings
  • AptarGroup Inc. - Segment focus
  • SWOT
• 15.5 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key offerings
  • SWOT
• 15.6 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 15.7 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.8 Gerresheimer AG
  • Gerresheimer AG - Overview
  • Gerresheimer AG - Business segments
  • Gerresheimer AG - Key offerings
  • Gerresheimer AG - Segment focus
  • SWOT
• 15.9 Halozyme Therapeutics Inc.
  • Halozyme Therapeutics Inc. - Overview
  • Halozyme Therapeutics Inc. - Product / Service
  • Halozyme Therapeutics Inc. - Key offerings
  • SWOT
• 15.10 ICU Medical Inc.
  • ICU Medical Inc. - Overview
  • ICU Medical Inc. - Product / Service
  • ICU Medical Inc. - Key offerings
  • SWOT
• 15.11 Insulet Corp.
  • Insulet Corp. - Overview
  • Insulet Corp. - Product / Service
  • Insulet Corp. - Key news
  • Insulet Corp. - Key offerings
  • SWOT
• 15.12 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.13 Nipro Corp.
  • Nipro Corp. - Overview
  • Nipro Corp. - Business segments
  • Nipro Corp. - Key offerings
  • Nipro Corp. - Segment focus
  • SWOT
• 15.14 Stevanato Group S.p.A
  • Stevanato Group S.p.A - Overview
  • Stevanato Group S.p.A - Product / Service
  • Stevanato Group S.p.A - Key offerings
  • SWOT
• 15.15 Tandem Diabetes Care Inc.
  • Tandem Diabetes Care Inc. - Overview
  • Tandem Diabetes Care Inc. - Product / Service
  • Tandem Diabetes Care Inc. - Key offerings
  • SWOT
• 15.16 Terumo Corp.
  • Terumo Corp. - Overview
  • Terumo Corp. - Business segments
  • Terumo Corp. - Key news
  • Terumo Corp. - Key offerings
  • Terumo Corp. - Segment focus
  • SWOT
• 15.17 West Pharma Services Inc.
  • West Pharma Services Inc. - Overview
  • West Pharma Services Inc. - Business segments
  • West Pharma Services Inc. - Key offerings
  • West Pharma Services Inc. - Segment focus
  • SWOT
• 15.18 Ypsomed Holding AG
  • Ypsomed Holding AG - Overview
  • Ypsomed Holding AG - Business segments
  • Ypsomed Holding AG - Key offerings
  • Ypsomed Holding AG - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations